| scholarly article | Q13442814 |
| P50 | author | Jagat Narula | Q56021238 |
| Chris P M Reutelingsperger | Q88125144 | ||
| P2093 | author name string | Werner H Mess | |
| Mat J A P Daemen | |||
| Leonard Hofstra | |||
| Bas L J H Kietselaer | |||
| Guido A K Heidendal | |||
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| atherosclerosis | Q12252367 | ||
| P304 | page(s) | 1472-3 | |
| P577 | publication date | 2004-04-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis | |
| P478 | volume | 350 |
| Q39878866 | (18)F-fluorodeoxyglucose PET imaging of coronary atherosclerosis and plaque inflammation |
| Q35030851 | (64)Cu-labeled LyP-1-dendrimer for PET-CT imaging of atherosclerotic plaque |
| Q56985984 | 2-deoxy-2-[18F]fluoro-d-mannose positron emission tomography imaging in atherosclerosis |
| Q79538242 | 99mTc-Annexin A5 for noninvasive characterization of atherosclerotic lesions: imaging and histological studies in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits |
| Q38005672 | A molecular imaging primer: modalities, imaging agents, and applications |
| Q47866518 | A review of molecular imaging of atherosclerosis and the potential application of dendrimer in imaging of plaque |
| Q94409734 | ACST: which subgroups will benefit most from carotid endarterectomy? |
| Q38052020 | Advances in molecular imaging of atherosclerosis and myocardial infarction: shedding new light on in vivo cardiovascular biology. |
| Q37284563 | Advances in molecular imaging of atherosclerotic vascular disease |
| Q57292350 | An innovative flow cytometry method to screen human scFv-phages selected by in vivo phage-display in an animal model of atherosclerosis |
| Q33678159 | Annexin A5-functionalized bimodal nanoparticles for MRI and fluorescence imaging of atherosclerotic plaques |
| Q37222172 | Arithmetic of vulnerable plaques for noninvasive imaging |
| Q46678565 | Arterial wall uptake of fluorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events |
| Q33377667 | Assessment of neuroprotection in the retina with DARC. |
| Q36390068 | Atherosclerosis imaging on the molecular level |
| Q36915500 | Biodegradable synthetic high-density lipoprotein nanoparticles for atherosclerosis |
| Q36841558 | Cardiovascular molecular imaging of apoptosis |
| Q37530107 | Cardiovascular molecular imaging: an overview |
| Q30470859 | Cardiovascular molecular imaging: focus on clinical translation |
| Q39283965 | Cell surface-expressed phosphatidylserine as therapeutic target to enhance phagocytosis of apoptotic cells |
| Q38742857 | Clinical imaging of vascular disease in chronic kidney disease |
| Q50698610 | Comparison of 99mTc-annexin A5 with 18F-FDG for the detection of atherosclerosis in ApoE-/- mice. |
| Q36337258 | Current imaging strategies in rheumatoid arthritis |
| Q38848673 | Detection and treatment of atherosclerosis using nanoparticles |
| Q39728613 | Detection of atherosclerotic plaques in ApoE-deficient mice using (99m)Tc-duramycin |
| Q39214883 | Direct coupling of annexin A5 to VSOP yields small, protein-covered nanoprobes for MR imaging of apoptosis |
| Q37352106 | Dual molecular imaging for targeting metalloproteinase activity and apoptosis in atherosclerosis: molecular imaging facilitates understanding of pathogenesis |
| Q48559001 | Fourth annual Mario S. Verani, MD Memorial Lecture: noninvasive imaging in coronary artery disease: changing roles, changing players |
| Q35577419 | High-resolution imaging of human atherosclerotic carotid plaques with micro 18F-FDG PET scanning exploring plaque vulnerability |
| Q56986839 | Identification of interleukin-2 for imaging atherosclerotic inflammation |
| Q38375518 | Imaging apoptosis in the eye. |
| Q36434865 | Imaging atherosclerosis with hybrid [18F]fluorodeoxyglucose positron emission tomography/computed tomography imaging: what Leonardo da Vinci could not see. |
| Q37222163 | Imaging atherosclerotic plaque inflammation. |
| Q34913604 | Imaging of apoptosis in the heart with nanoparticle technology |
| Q37407240 | Imaging of the unstable plaque: how far have we got? |
| Q80796551 | Imaging of unstable atherosclerotic lesions |
| Q37535498 | Imaging outcomes in cardiovascular clinical trials |
| Q37244485 | Imaging the cellular biology of the carotid plaque. |
| Q47693523 | In vivo molecular imaging of apoptosis and necrosis in atherosclerotic plaques using microSPECT-CT and microPET-CT imaging |
| Q37222177 | Intracellular and extracellular targets of molecular imaging in the myocardium |
| Q37400823 | Lantibiotics as probes for phosphatidylethanolamine |
| Q50567621 | Localization of deoxyglucose and annexin A5 in experimental atheroma correlates with macrophage infiltration but not lipid deposition in the lesion |
| Q52694389 | Molecular Imaging in Drug Discovery and Development. |
| Q28070313 | Molecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models |
| Q37435637 | Molecular MRI detects low levels of cardiomyocyte apoptosis in a transgenic model of chronic heart failure. |
| Q36700579 | Molecular cardiovascular imaging using scintigraphic methods |
| Q37557366 | Molecular imaging in cardiovascular disease: targets and opportunities |
| Q37825149 | Molecular imaging metrics to evaluate response to preclinical therapeutic regimens |
| Q37139934 | Molecular imaging of atherosclerosis |
| Q36141999 | Molecular imaging of atherosclerosis for improving diagnostic and therapeutic development |
| Q41819473 | Molecular imaging of atherosclerosis: clinical state-of-the-art |
| Q37441796 | Molecular imaging of cell death |
| Q38700322 | Molecular imaging of high-risk atherosclerotic plaques: is it clinically translatable? |
| Q30446268 | Molecular imaging of inflammation in atherosclerosis |
| Q34498697 | Molecular imaging of plaque vulnerability |
| Q50708993 | Molecular imaging of vascular cell adhesion molecule-1 expression in experimental atherosclerotic plaques with radiolabelled B2702-p. |
| Q40361537 | Molecular imaging of vulnerable atherosclerotic plaques |
| Q38043973 | Molecular imaging to identify the vulnerable plaque--from basic research to clinical practice |
| Q30482989 | Molecular imaging: 18F-FDG PET and a whole lot more. |
| Q30438207 | Multimodality cardiovascular molecular imaging, Part II |
| Q38089761 | Nanotechnology in the diagnosis of atherosclerotic disease |
| Q27011866 | New SPECT and PET radiopharmaceuticals for imaging cardiovascular disease |
| Q51730474 | New methods to image unstable atherosclerotic plaques. |
| Q26992143 | Non-invasive imaging of atherosclerosis |
| Q37002304 | Noninvasive imaging of apoptosis in cardiovascular disease. |
| Q43134225 | PET/CT imaging of atherosclerotic blood vessel alterations |
| Q37417701 | Pathophysiology of coronary artery disease: the case for multiparametric imaging. |
| Q30455490 | Perspectives and opportunities for nanomedicine in the management of atherosclerosis. |
| Q37741860 | Phosphatidylserine targeting for diagnosis and treatment of human diseases |
| Q37050963 | Positron emission tomography imaging of coronary atherosclerosis |
| Q37438144 | Pre-clinical and clinical evaluation of nuclear tracers for the molecular imaging of vulnerable atherosclerosis: an overview |
| Q30577193 | Radiolabelled probes for imaging of atherosclerotic plaques. |
| Q38260613 | Radionuclide Imaging of Apoptosis in Malignancies: Promise and Pitfalls of Tc-Hynic-rh-Annexin V Imaging |
| Q37196226 | Radionuclide imaging: a molecular key to the atherosclerotic plaque |
| Q49352380 | Radiopharmaceutical tracers for cardiac imaging. |
| Q55515767 | Real-Time Imaging of Retinal Ganglion Cell Apoptosis. |
| Q39043966 | Recent Advances in the Development of PET/SPECT Probes for Atherosclerosis Imaging |
| Q37746356 | SPECT and PET radiopharmaceuticals for molecular imaging of apoptosis: from bench to clinic |
| Q36090166 | Targeting the vulnerable plaque: the evolving role of nuclear imaging |
| Q46535633 | The atherosclerotic plaque: a healthy challenge to the limits of nuclear imaging |
| Q54911978 | The year in molecular imaging. |
| Q41829834 | Visualization of cell death in mice with focal cerebral ischemia using fluorescent annexin A5, propidium iodide, and TUNEL staining |
| Q38187881 | Visualizing the atherosclerotic plaque: a chemical perspective |
| Q38135890 | What can we learn about valvular heart disease from PET/CT? |
| Q84564417 | Who gets the heart attack: noninvasive imaging markers of plaque instability |
| Q37729836 | Will molecular optical imaging have clinically important roles in stroke management, and how? |
| Q79449729 | [Advances in cardiovascular medicine through molecular imaging] |
Search more.